Cargando…

Drugs acting on central nervous system (CNS) targets as leads for non-CNS targets

Innovative drug discovery approaches are currently needed to rejuvenate the shrinking product pipelines of the pharmaceutical companies across the globe. Here a theme is presented – the use of central nervous system (CNS) drugs as leads for non-CNS targets. The approach is related to the use of exis...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kharkar, Prashant S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961999/ https://www.ncbi.nlm.nih.gov/pubmed/24715979 http://dx.doi.org/10.12688/f1000research.3-40.v2

Ejemplares similares

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery
por: Ghose, Arup K., et al.
Publicado: (2011)

Central Nervous System (CNS) and Systemic Autoimmune Disease: Coexistence or More?
por: Vibha, Deepti, et al.
Publicado: (2022)

Microtubule-Targeting Agents Enter the Central Nervous System (CNS): Double-edged Swords for Treating CNS Injury and Disease
por: Hur, Eun-Mi, et al.
Publicado: (2014)

IMG-04. POTENTIAL TARGETS FOR THERANOSTICS IN PEDIATRIC HIGH-GRADE CENTRAL NERVOUS SYSTEM (CNS) TUMORS
por: Plasschaert, Sabine, et al.
Publicado: (2023)

Central Nervous System (CNS) Delivery of Glucocorticoids Is Fine-Tuned by Saturable Transporters at the Blood-CNS Barriers and Nonbarrier Regions
por: Mason, Brittany L., et al.
Publicado: (2010)

Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathology
por: Hao, Junwei, et al.
Publicado: (2010)

PB2334: CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: CNS-SAMATYA RISK MODEL
por: Yokus, Osman, et al.
Publicado: (2023)

Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin’s Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease
por: Huang, Shuang, et al.
Publicado: (2021)

Non-Genetic Modifiers of Synaptic Plasticity and Neurotransmission in the Central Nervous System (CNS) in Health and Disease
por: Grabrucker, Andreas M.
Publicado: (2022)

LINC-43. FACTORS LEADING TO DIAGNOSTIC DELAY FOR CHILDREN WITH PRIMARY TUMORS OF CENTRAL NERVOUS SYSTEM (CNS) IN QATAR
por: Yousif, Tayseer, et al.
Publicado: (2020)

The choline pathway as a strategy to promote central nervous system (CNS) remyelination
por: Skripuletz, Thomas, et al.
Publicado: (2015)

Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors
por: Nowacka, Agnieszka, et al.
Publicado: (2018)

Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination
por: Abu-Rub, Mohammad, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease
por: Kamath, Suneel D., et al.
Publicado: (2018)

The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity
por: Thompson, Kaitlyn K., et al.
Publicado: (2017)

1302. HIV Testing in Adults Presenting with Central Nervous System (CNS) Infections
por: Ma, Bert, et al.
Publicado: (2019)

Modeling the blood-brain barrier for treatment of central nervous system (CNS) diseases
por: Rice, Olivia, et al.
Publicado: (2022)

Emerging and Re-Emerging Parasitic Infections of the Central Nervous System (CNS) in Europe
por: Tunali, Varol, et al.
Publicado: (2023)

CNS-targeted autoimmunity leads to increased influenza mortality in mice
por: Glenn, Justin D., et al.
Publicado: (2017)

Central Nervous System (CNS) Viral Seeding by Mature Monocytes and Potential Therapies To Reduce CNS Viral Reservoirs in the cART Era
por: León-Rivera, Rosiris, et al.
Publicado: (2021)

Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
por: Warren, Katherine Elizabeth
Publicado: (2018)

The Incidence and Prevalence of Primary Central Nervous System (CNS) Tumours in Canada (2010–2017), and the Survival of Patients Diagnosed with CNS Tumours (2008–2017)
por: Walker, Emily V., et al.
Publicado: (2023)

Occurrence of Spontaneous Tumors in the Central Nervous System (CNS) of F344 and SD Rats
por: Nagatani, Mariko, et al.
Publicado: (2013)

Central nervous system (CNS) involvement is a critical prognostic factor for hemophagocytic lymphohistiocytosis
por: Kim, Myung-Mi, et al.
Publicado: (2012)

Lymphomatoid granulomatosis of the central nervous system (CNS‐LYG) posing a management challenge
por: Soleja, Mohsin, et al.
Publicado: (2021)

Unique Chemistry, Intake, and Metabolism of Polyamines in the Central Nervous System (CNS) and Its Body
por: Rieck, Julian, et al.
Publicado: (2022)

Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective
por: Ndondo, Alvin Pumelele, et al.
Publicado: (2022)

CNS and CNS diseases in relation to their immune system
por: Xu, Jianhao, et al.
Publicado: (2022)

Antibody-based Validation of CNS Ion Channel Drug Targets
por: Rhodes, Kenneth J., et al.
Publicado: (2008)

L-type calcium channels as drug targets in CNS disorders
por: Ortner, Nadine J, et al.
Publicado: (2015)

HIV persistence in the CNS: the final frontier for a cure?
por: Lewin, Sharon R, et al.
Publicado: (2016)

B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
por: Michel, Laure, et al.
Publicado: (2015)

Successful Use of Ertapenem for the Treatment of Enterobacter cloacae Complex Infection of the Central Nervous System (CNS)
por: Shah, Sunish, et al.
Publicado: (2019)

Imaging for central nervous system (CNS) interstitial fluidopathy: disorders with impaired interstitial fluid dynamics
por: Taoka, Toshiaki, et al.
Publicado: (2020)

OTHR-02. MULTIMODALITY TREATMENT FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM (CNS) TUMOR IN OUR INSTITUTE
por: Sasano, Mari, et al.
Publicado: (2020)

A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

Effects of Resistance Training on Skin Temperature and Its Relationship with Central Nervous System (CNS) Activation
por: Sillero-Quintana, Manuel, et al.
Publicado: (2022)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
por: Sági, Judit C., et al.
Publicado: (2021)

EPID-02. Survival Experience in Pediatric Patients of Central Nervous System (CNS) Tumour in Canada
por: Yuan, Yan, et al.
Publicado: (2022)

Central Nervous System (CNS) T-Cell Lymphoma as the Presenting Manifestation of Late-Onset Combined Immunodeficiency
por: Jeffrey, Anthony, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8195n201vfv7sisqcqt7ae569f